Literature DB >> 19911888

Resection of malignant brain tumors in eloquent cortical areas: a new multimodal approach combining 5-aminolevulinic acid and intraoperative monitoring.

Guenther C Feigl1, Rainer Ritz, Mario Moraes, Jan Klein, Kristofer Ramina, Alireza Gharabaghi, Boris Krischek, Soeren Danz, Antje Bornemann, Marina Liebsch, Marcos S Tatagiba.   

Abstract

OBJECT: Several studies have revealed that the gross-total resection (GTR) of malignant brain tumors has a significant influence on patient survival. Frequently, however, GTR cannot be achieved because the borders between healthy brain and diseased tissue are blurred in the infiltration zones of malignant brain tumors. Especially in eloquent cortical areas, resection is frequently stopped before total removal is achieved to avoid causing neurological deficits. Interestingly, 5-aminolevulinic acid (5-ALA) has been shown to help visualize tumor tissue intraoperatively and, thus, can significantly improve the possibility of achieving GTR of primary malignant brain tumors. The aim of this study was to go one step further and evaluate the utility and limitations of fluorescence-guided resections of primary malignant brain tumors in eloquent cortical areas in combination with intraoperative monitoring based on multimodal functional imaging data.
METHODS: Eighteen patients with primary malignant brain tumors in eloquent areas were included in this prospective study. Preoperative neuroradiological examinations included MR imaging with magnetization-prepared rapid gradient echo (MPRAGE), functional MR, and diffusion tensor imaging sequences to visualize functional areas and fiber tracts. Imaging data were analyzed offline, loaded into a neuronavigational system, and used intraoperatively during resections. All patients received 5-ALA 6 hours before surgery. Fluorescence-guided tumor resections were combined with intraoperative monitoring and cortical as well as subcortical stimulation to localize functional areas and fiber tracts during surgery.
RESULTS: Twenty-five procedures were performed in 18 consecutive patients. In 24% of all surgeries, resection was stopped because a functional area or cortical tract was identified in the resection area or because motor evoked potential amplitudes were reduced in an area where fluorescent tumor cells were still seen intraoperatively. Grosstotal resection could be achieved in 16 (64%) of the surgeries with preservation of all functional areas and fiber tracts. In 2 patients presurgical hemiparesis became accentuated postoperatively, and 1 of these patients also suffered from a new homonymous hemianopia following a second resection.
CONCLUSIONS: The authors' first results show that tumor resections with 5-ALA in combination with intraoperative cortical stimulation have the advantages of both methods and, thus, provide additional safety for the neurosurgeon during resections of primary malignant brain tumors in eloquent areas. Nonetheless, more cases and additional studies are necessary to further prove the advantages of this multimodal strategy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19911888     DOI: 10.3171/2009.10.JNS09447

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  24 in total

Review 1.  Intraoperative assistive technologies and extent of resection in glioma surgery: a systematic review of prospective controlled studies.

Authors:  Breno José Alencar Pires Barbosa; Eric Domingos Mariano; Chary Marquez Batista; Suely Kazue Nagahashi Marie; Manoel Jacobsen Teixeira; Carlos Umberto Pereira; Marcos Soares Tatagiba; Guilherme Alves Lepski
Journal:  Neurosurg Rev       Date:  2014-12-04       Impact factor: 3.042

2.  Surgical results of tumor resection using tractography-integrated navigation-guided fence-post catheter techniques and motor-evoked potentials for preservation of motor function in patients with glioblastomas near the pyramidal tracts.

Authors:  Shiro Ohue; Shohei Kohno; Akihiro Inoue; Daisuke Yamashita; Shirabe Matsumoto; Satoshi Suehiro; Yoshiaki Kumon; Keiichi Kikuchi; Takanori Ohnishi
Journal:  Neurosurg Rev       Date:  2014-11-19       Impact factor: 3.042

3.  Beyond eloquence and onto centrality: a new paradigm in planning supratentorial neurosurgery.

Authors:  Syed Ali Ahsan; Kassem Chendeb; Robert G Briggs; Luke R Fletcher; Ryan G Jones; Arpan R Chakraborty; Cameron E Nix; Christina C Jacobs; Alison M Lack; Daniel T Griffin; Charles Teo; Michael Edward Sughrue
Journal:  J Neurooncol       Date:  2020-01-01       Impact factor: 4.130

4.  Feasibility of fluorescence-guided resection of recurrent gliomas using five-aminolevulinic acid: retrospective analysis of surgical and neurological outcome in 58 patients.

Authors:  Anne-Katrin Hickmann; Minou Nadji-Ohl; Nikolai J Hopf
Journal:  J Neurooncol       Date:  2015-01-04       Impact factor: 4.130

5.  Surgery guided by 5-aminolevulinic fluorescence in glioblastoma: volumetric analysis of extent of resection in single-center experience.

Authors:  Ricardo Díez Valle; Sonia Tejada Solis; Miguel Angel Idoate Gastearena; Reyes García de Eulate; Pablo Domínguez Echávarri; Javier Aristu Mendiroz
Journal:  J Neurooncol       Date:  2010-07-06       Impact factor: 4.130

Review 6.  Advances in the Surgical Management of Low-Grade Glioma.

Authors:  Todd Hollon; Shawn L Hervey-Jumper; Oren Sagher; Daniel A Orringer
Journal:  Semin Radiat Oncol       Date:  2015-02-23       Impact factor: 5.934

Review 7.  How Intraoperative Tools and Techniques Have Changed the Approach to Brain Tumor Surgery.

Authors:  Parastou Fatemi; Michael Zhang; Kai J Miller; Pierre Robe; Gordon Li
Journal:  Curr Oncol Rep       Date:  2018-09-26       Impact factor: 5.075

Review 8.  The role of 5-aminolevulinic acid in brain tumor surgery: a systematic review.

Authors:  Nicholas Ferraro; Eric Barbarite; Trevine R Albert; Emmanuel Berchmans; Ashish H Shah; Amade Bregy; Michael E Ivan; Tyler Brown; Ricardo J Komotar
Journal:  Neurosurg Rev       Date:  2016-01-27       Impact factor: 3.042

Review 9.  Fluorescence Guidance and Intraoperative Adjuvants to Maximize Extent of Resection.

Authors:  Cordelia Orillac; Walter Stummer; Daniel A Orringer
Journal:  Neurosurgery       Date:  2021-10-13       Impact factor: 4.654

10.  Impact of fluorescence-guided surgery on the improvement of clinical outcomes in glioblastoma patients.

Authors:  Sung Kwon Kim; Seung Hong Choi; Yong Hwy Kim; Chul-Kee Park
Journal:  Neurooncol Pract       Date:  2014-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.